Efficacy and tolerability of Ze 117 St. John's wort extract in comparison with placebo, imipramine and fluoxetine for the treatment of mild to moderate depression according to ICD-10.: An overview

被引：9

作者：

Käufeler, R ^{[1
]}

Meier, B ^{[1
]}

Brattström, A ^{[1
]}

机构：

[1] Max Zeller Sohne AG, Herbal Remedies, CH-8590 Romanshorn 1, Switzerland

来源：

PHARMACOPSYCHIATRY | 2001年 / 34卷

关键词：

D O I：

10.1055/s-2001-15457

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：S49 / S50

页数：2

共 23 条

[1] Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression
Schrader, E
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2000, 15 (02) : 61 - 68
[2] Efficacy and tolerability of St. John's Wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10
Vorbach, EU
Arnoldt, KH
Hubner, WD
PHARMACOPSYCHIATRY, 1997, 30 : 81 - 85
[3] Efficacy of St. John's Wort for Treating Mild to Moderate Depression
Gahlsdorf, Tera
Krause, Robert
Beal, Margaret W.
JOURNAL OF EVIDENCE-BASED INTEGRATIVE MEDICINE, 2007, 12 (03): : 184 - 195
[4] Potential treatment for subthreshold and mild depression: A comparison of St. John's wort extracts and fluoxetine
Volz, HP
Laux, P
COMPREHENSIVE PSYCHIATRY, 2000, 41 (02) : 133 - 137
[5] Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort
Röder, C
Schaefer, M
Leucht, S
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2004, 72 (06) : 330 - 343
[6] Efficacy of St. John's wort extract WS® 5570 in acute treatment of mild depression
Kasper, S.
Gastpar, M.
Muller, W. E.
Volz, H. P.
Dienel, A.
Kieser, M.
Moeller, H. J.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2007, 258 (01) : 59 - 63
[7] Evaluating the cost-effectiveness of St. John's Wort versus fluoxetine for the treatment of mild to moderate depression
Thayer, LA
Scott, VG
Nau, DP
Rosenbluth, S
Makela, G
VALUE IN HEALTH, 2003, 6 (03) : 357 - 357
[8] Antidepressive pharmacotherapy in mild to moderate depression - A comparison of extracts of St John's wort and fluoxetine
Volz, HP
Laux, P
PSYCHOPHARMAKOTHERAPIE, 1999, 6 (04): : 138 - 142
[9] St. John's Wort in mild to moderate depression: The relevance of hyperforin for the clinical efficacy
Laakmann, G
Schule, C
Baghai, T
Kieser, M
PHARMACOPSYCHIATRY, 1998, 31 : 54 - 59
[10] Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression
Solomon, Daniela
Adams, Jon
Graves, Nicholas
JOURNAL OF AFFECTIVE DISORDERS, 2013, 148 (2-3) : 228 - 234

← 1 2 3 →